Viewing Study NCT00469859


Ignite Creation Date: 2025-12-24 @ 2:43 PM
Ignite Modification Date: 2026-02-22 @ 7:23 PM
Study NCT ID: NCT00469859
Status: COMPLETED
Last Update Posted: 2017-03-15
First Post: 2007-05-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Children's Oncology Group
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: AAML06P1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View